Commodore Capital
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
444 Madison Ave Fl 35, New York City, Ne...Phone Number
(212) 256-8600Website
www.commodorecapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
1
1
About Commodore Capital
Commodore Capital focuses on investing in innovative biopharmaceutical companies that aim to improve patients' lives. The company recognizes the ongoing innovation cycle in the biopharmaceutical sector, particularly with advancements in genetic medicines and cellular therapies. Unlike previous decades dominated by large pharmaceutical firms, Commodore Capital partners with smaller companies to support the development of new, safe, and effective medicines. Their goal is to facilitate the translation of scientific discoveries into clinical breakthroughs for patients worldwide.Explore more
Commodore Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Commodore Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Commodore Capital recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Commodore Capital is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Commodore Capital
Product Launch: Get notified when Commodore Capital launches new products
Check if Commodore Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Commodore Capital had a recent Job posting/layoffs
Commodore Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Commodore Capital has new funding data
Recommended Actions
Find VP level buyers at Commodore Capital
Find 3 more new buyers
Compare Similar Companies to Commodore Capital
Compare insights from companies similar to Commodore Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$24.6M
11-50
Private
-
1983
CS
Corrin SuttonPrincipal and Chief Financial Officer and Chief Compliance Officer
Company Profile Activity
Activity Insights
Commodore Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Commodore Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Commodore Capital.
Commodore Capital Tech Stack
A closer look at the technologies used by Commodore Capital
Commodore Capital News & Media
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away
This investor just walked away as Scholar Rock heads into a pivotal 2026—here’s what that means for long-term shareholders.Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors
One fast-rising biotech just landed a heavyweight backer ahead of a pivotal presentation—here’s what investors should watch.Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares
Relay’s comeback is gaining momentum—does this latest move signal rising conviction in its pipeline?IDRx Raises $120M in Series B Financing
IDRx, a Plymouth, MA-based clinical-stage biopharmaceutical company, raised $120M in Series B funding. The round was led by RA Capital Management, Commodore Capital, and Blackstone Multi-Asset Investing with additional new investors, including Rock Springs Capital and a U.S.-based healthcare-focused fund. Existing investors, including Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, Nextech Invest Ltd. (on […] The post IDRx Raises $120M in Series B Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Frequently Asked Questions Regarding Commodore Capital
Sign Up For FreeTo access detailed company insights
Commodore Capital focuses on investing in innovative biopharmaceutical companies that aim to improve patients' lives. The company recognizes the ongoing innovation cycle in the biopharmaceutical sector, particularly with advancements in genetic medicines and cellular therapies. Unlike previous decades dominated by large pharmaceutical firms, Commod... Read More
